ClinicalTrials.Veeva

Menu

The Effect of High Flow Oxygen Therapy Via Tracheostomy on Diaphragm Function

E

Evangelismos Hospital

Status

Unknown

Conditions

Weaning Failure

Treatments

Device: High Flow Oxygen Therapy
Device: T-piece

Study type

Interventional

Funder types

Other

Identifiers

NCT04758910
No 771 2019

Details and patient eligibility

About

While the high flow oxygen therapy (HFOT) respiratory support system, delivered through nasal cannulas, has demonstrated clinical benefits on respiratory function, limited data exist on whether such effects are also present in HFOT through tracheostomy. Therefore, the aim of the proposed study is to examine the short-term effects of HFOT as opposed to oxygen therapy via T-piece on diaphragmatic function in tracheostomized patients with prolonged weaning from mechanical ventilation.

Full description

Critically ill patients who experience difficulties in weaning from the ventilator often undergo tracheostomy. These patients usually undergo spontaneous breathing trials receiving oxygen via T-piece. While the high flow oxygen therapy (HFOT) respiratory support system, delivered through nasal cannulas, has demonstrated clinical benefits on respiratory function, limited data exist on whether such effects are also present in HFOT through tracheostomy. Therefore, we plan to perform a study to examine the short-term effects of HFOT on diaphragmatic function in tracheostomized patients with prolonged weaning from mechanical ventilation.

After disconnection from the ventilator, patients will undergo a 30-minute spontaneous breathing trial receiving oxygen either conventionally via T-piece, or by HFOT delivered via tracheostomy, followed by a washout period of 15 min breathing through T-piece and 30 min receiving oxygen with the other modality in a randomized manner. At the start and end of each study period, patients will undergo an assessment through diaphragm ultrasonography, which includes excursion of diaphragmatic dome and thickness of diaphragmatic zone of apposition at end-inspiration and end-expiration. Subsequently, the diaphragmatic thickening fraction will be calculated as the difference between end-inspiratory and end-expiratory thickness divided by end-expiratory thickness. Also. arterial blood gases as well as respiratory rate (RR) and tidal volume (TV) (through a Wright's spirometer) will be measured.

Enrollment

30 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Mechanically ventilated patients with prolonged weaning and tracheostomy

Exclusion criteria

  • pregnancy

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

None (Open label)

30 participants in 2 patient groups

High Flow Oxygen Therapy
Active Comparator group
Description:
Tracheostomized patients will undergo a spontaneous breathing trial with high flow oxygen therapy.
Treatment:
Device: High Flow Oxygen Therapy
T-piece
Active Comparator group
Description:
Tracheostomized patients will undergo a spontaneous breathing trial with T-piece as a standard of care.
Treatment:
Device: T-piece

Trial contacts and locations

0

Loading...

Central trial contact

Spyros Zakynthinos, MD; Christina I Routsi, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems